首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1800801

2025 年至 2033 年流式細胞儀市場報告（按產品和服務、技術、應用、最終用戶和地區分類）

Flow Cytometry Market Report by Product and Service, Technology, Application, End-User, and Region 2025-2033

出版日期: 2025年08月01日 | 出版商:

IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2024年，全球流式細胞儀市場規模達62億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到113億美元，2025-2033年期間的複合年成長率（CAGR）為6.91%。個人化醫療中產品的廣泛應用、生命科學和生物技術領域研究活動的擴展以及學術和研究機構資金的加速成長是推動市場發展的主要因素。

流式細胞儀是一種能夠對異質細胞群中的單一細胞進行詳細多參數分析的技術。該技術利用光來檢測和測量細胞群或顆粒的物理和化學特性。每個顆粒懸浮在流體流中，並通過電子檢測裝置。一束光照射到流體流上，光散射是顆粒及其特性的特徵。這些模式的強度可用於獲取有關每個細胞物理和化學結構的各種資料。這些資訊在包括診斷和生物醫學研究在內的廣泛應用中非常有價值。它可以每秒快速分析數千個顆粒，並同時收集有關單一細胞的多個參數的資料。因此，它是細胞生物學和醫學中必不可少的工具。

生命科學和生物技術領域研究活動的擴展是全球市場的主要驅動力。它是細胞生物學、免疫學和腫瘤學研究中的關鍵工具，廣泛應用於細胞週期、增殖、凋亡以及其他細胞功能的研究。這些研究領域的投資不斷增加，尤其是在發展中國家，這影響了對這些儀器、試劑和軟體的需求。此外，該方法在疾病檢測和監測方面的精確性和高效性使其成為個人化醫療的理想選擇。隨著這種醫療模式的採用率不斷上升，它正在顯著推動市場的成長。此外，學術和研究機構（尤其是從事細胞研究的機構）的資金投入不斷增加，也為市場帶來了巨大的動力。這些資金促進了先進細胞計數技術的採購和新應用的開發，從而推動了整體市場的成長。此外，人們對早期診斷和治療益處的認知不斷提高，加上中產階級人口的不斷成長，也為市場帶來了積極的前景。

流式細胞儀市場趨勢/促進因素：

慢性病盛行率不斷上升

癌症、愛滋病毒/愛滋病等慢性疾病以及其他免疫系統相關疾病的發生率不斷上升，大大推動了對流式細胞儀的需求。此外，流式細胞儀在多種血液系統惡性腫瘤的診斷和預後中也發揮著不可或缺的作用，並且擴大用於監測病情進展和治療反應。隨著全球人口老化和此類疾病的盛行率上升，對快速、準確的診斷和監測工具的需求也日益成長。因此，醫療保健產業持續致力於提供有效的治療方案並改善患者的生活品質，這成為流式細胞儀市場的重要驅動力。

臨床試驗和藥物研發的應用增加

流式細胞儀在臨床試驗和藥物研發的廣泛應用是重要的市場驅動力。此外，流式細胞儀能夠提供有關單一細胞和細胞群的詳細資訊，使其成為評估藥物效果和識別潛在治療靶點的理想選擇。此外，製藥公司越來越依賴這些方法進行臨床前測試和臨床試驗，以評估新藥的安全性和有效性。因此，它正在對市場產生積極的影響。隨著製藥業的擴張和新候選藥物數量的不斷增加，該領域對流式細胞儀的需求正在大幅成長，從而推動了市場的整體成長。

持續的技術進步

流式細胞儀產業的主要市場驅動力之一是該領域的持續技術進步。高通量流式細胞儀的出現、提供更佳資料分析的軟體解決方案的進步以及特定探針和試劑的開發，顯著提高了流式細胞儀的效率。此外，緊湊、方便用戶使用且價格合理的系統的推出，也推動了該技術的普及，使其應用範圍從研究實驗室擴展到臨床環境，甚至應用於即時診斷。多色檢測方法和試劑的興起也使得能夠同時檢測多種參數，進一步增強了其檢測能力。這些進步不僅提供了更有效率、更可靠的結果，也拓寬了潛在的應用範圍，從而促進了市場的成長。

市場結構
關鍵參與者
關鍵參與者簡介
- Agilent Technologies Inc.
- Apogee Flow Systems Ltd.
- BD (Becton, Dickinson and Company)
- Beckman Coulter Inc. (Danaher Corporation)
- Bio-RAD Laboratories Inc.
- Enzo Life Sciences Inc.
- Luminex Corporation
- Merck KGaA
- Sony Biotechnology Inc.
- Sysmex Partec GmbH
- Thermo Fisher Scientific Inc.

簡介目錄圖表

Product Code: SR112025A2272

The global flow cytometry market size reached USD 6.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.3 Billion by 2033, exhibiting a growth rate (CAGR) of 6.91% during 2025-2033. The widespread product adoption in personalized medicine, the expansion of research activities in life sciences and biotechnology, and the accelerating funding for academic and research institutes are some of the major factors propelling the market.

Flow cytometry is a technology that allows detailed multi-parameter analysis of individual cells within a heterogeneous population. This technique uses light to detect and measure physical and chemical properties of a population of cells or particles. Each particle is suspended in a stream of fluid and passed through an electronic detection apparatus. A beam of light is directed onto the stream, and the light scatter is characteristic of the particles and their properties. The intensity of these patterns can be used to derive various types of data about the physical and chemical structure of each cell. This information is valuable in a wide range of applications, including diagnostics and biomedical research. It can quickly analyze thousands of particles per second and concurrently gather data about multiple parameters of a single cell. Therefore, it is an essential tool in cell biology and medicine.

The expansion of research activities in life sciences and biotechnology majorly drives the global market. It is a crucial tool in cell biology, immunology, and oncology research. It is extensively used in the study of cell cycle and proliferation, apoptosis, and other cellular functions. The rising investments in these research areas, especially in developing countries, have influenced the demand for these instruments, reagents, and software. In addition, the precision and efficiency of these method in the detection and monitoring of diseases make it ideal for personalized medicine. As this medical model continues to rise in adoption, it is significantly driving the growth of the market. Apart from this, the accelerating funding for academic and research institutes, particularly those engaged in cell-based research, has been a considerable driver for the market. These funds facilitate the purchase of advanced cytometry technologies and the development of new applications, driving the overall market growth. Moreover, the accelerating awareness about the benefits of early diagnosis and therapeutics, coupled with a growing middle-class population is creating a positive market outlook.

Flow Cytometry Market Trends/Drivers:

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases such as cancer, HIV/AIDS, and other immune system-related diseases has substantially driven the demand for flow cytometry. Along with this, flow cytometry is indispensable in the diagnosis and prognosis of several hematological malignancies and is increasingly being used in monitoring disease progression and treatment response. As the global population ages and the prevalence of such diseases increases, the need for fast, accurate diagnostic and monitoring tools also grows. Consequently, the healthcare sector's ongoing efforts to provide effective treatments and improve patients' quality of life act as a significant driving force for the flow cytometry market.

Increased Adoption in Clinical Trials and Drug Discovery

The widespread adoption of the method in clinical trials and drug discovery is a significant market driver. In addition, flow cytometry's ability to provide detailed information about individual cells and cellular populations makes it ideal for evaluating drug effects and identifying potential therapeutic targets. Apart from this, pharmaceutical companies are increasingly relying on these methods for preclinical testing and clinical trials to assess the safety and efficacy of new drugs. Therefore, it is positively influencing the market. With the expanding pharmaceutical industry and escalating number of new drug candidates, the demand for flow cytometry in this domain is accelerating substantially, driving the overall growth of the market.

Continuous Technological Advancements

One of the primary market drivers for the flow cytometry industry is the continued technological advancements in this field. The emergence of high-throughput flow cytometry, advancement in software solutions that offer better data analysis, and development of specific probes and reagents have significantly improved the efficacy of flow cytometry. Additionally, the introduction of compact, user-friendly, and affordable systems has led to the democratization of this technology, expanding its use from research labs to clinical settings and even point-of-care diagnostics. There has also been a rise in multicolor assays and reagents which allow simultaneous detection of many parameters, further enhancing the capabilities. These advancements not only provide more efficient and reliable results but also widen the range of potential applications, thereby contributing to the growth of the market.

Flow Cytometry Industry Segmentation:

Breakup by Product and Service:

Instruments
Reagents and Consumables
Accessories
Software
Services

Instruments dominate the market

In the industry, market drivers for instruments and services are multifaceted. As instruments become more precise, user-friendly, and affordable, they facilitate an expanded range of applications, thus driving demand. In addition, the development of portable and benchtop flow cytometers has made the technology more accessible, boosting the sales of these instruments. Services related to flow cytometry, such as maintenance, training, and data analysis, also experience increased demand driven by the growing usage of this method in various sectors. The complexity of the method data requires specialized software and skilled professionals for analysis, making these services critical. As more businesses and research institutions adopt flow cytometry, they often seek out these services to ensure effective operation and accurate results, further propelling the market for these services.

Breakup by Technology:

Cell-Based Flow Cytometry
Bead-Based Flow Cytometry

Cell-based flow cytometry dominates the market

The market for cell-based technology in the industry is driven by the increasing incidence of diseases such as cancer, where it plays a critical role in diagnosis and monitoring. This technology provides valuable information about cellular characteristics and behavior, making it crucial for understanding disease progression and treatment response. In addition, advancements in cell-based research, including stem cell research and cell therapeutics, contribute significantly to the market growth. These fields require in-depth cellular analysis, and flow cytometry is a key tool to meet these needs. In addition, the growing interest in personalized medicine, which requires precise information at the cellular level to develop individualized treatment strategies, is another driving factor. Moreover, the rise of single-cell analysis in genomics and proteomics is boosting the demand for cell-based flow cytometry, given its capability to analyze individual cells within a population.

Breakup by Application:

Oncology
Drug Discovery
Disease Diagnosis
Stem Cell Therapy
Organ Transplantation
Hematology
Others

Oncology dominates the market

The market in the field of oncology is largely driven by the rising global incidence of cancer and the indispensable role of this method in cancer research and patient management. Flow cytometry provides rapid, detailed analysis of cell populations, making it essential for diagnosing various forms of cancer, particularly hematological malignancies. It is also widely used for monitoring disease progression and response to treatment, thereby contributing to the decision-making process in cancer management. In confluence with this, the esclating adoption of personalized medicine in oncology, which requires high-resolution cellular analysis to develop tailored treatment strategies, further propels the demand for flow cytometry. Additionally, advancements in flow cytometry technology, such as the development of multicolor flow cytometry, have significantly enhanced its capabilities in cancer research.

Breakup by End-User:

Hospitals and Clinics
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Others

Hospitals and clinics dominate the market

The market within hospitals and clinics is being driven by the growing prevalence of diseases that require flow cytometry for diagnosis and monitoring, such as cancers and immunological disorders. As the patient load for these conditions grows, so does the need for rapid, accurate diagnostic tools in these healthcare settings. Moreover, technological advancements have resulted in more compact and user-friendly flow cytometers, making it easier for hospitals and clinics to adopt this technology. The rise of personalized medicine also promotes the use of flow cytometry in these settings, as it provides the detailed cellular analysis needed for personalized treatment strategies. In addition, as this method becomes more recognized for its ability to deliver fast and comprehensive results, insurance providers are increasingly covering flow cytometry-based tests, further promoting its adoption in hospitals and clinics.

Breakup by Region:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America exhibits a clear dominance, accounting for the largest flow cytometry market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The growth of the flow cytometry industry in North America is driven by a well-established healthcare infrastructure and robust research environment, both of which foster the adoption and development of advanced technologies. Along with this, the high incidence of chronic diseases such as cancer, where this method plays a crucial role in diagnosis and monitoring, also contributes to market growth. Additionally, the presence of leading companies in this region supports the development of innovative technologies and applications. Furthermore, the significant investment in research and development, including biomedical research, clinical trials, and drug discovery processes that extensively use flow cytometry, further fuels market growth. The region's growing interest in personalized medicine, which requires detailed cellular analysis provided by flow cytometry, also contributes to the market demand.

Competitive Landscape:

The global flow cytometry market is experiencing significant growth due to the growing investments in research and development to create advanced flow cytometry technologies. This includes the development of new instruments, reagents, software, and methodologies. These advancements aim to enhance the capabilities of flow cytometry, making it more precise, efficient, and user-friendly. Along with this, the escalating number of strategic partnerships with other businesses, research institutions, and healthcare providers is significantly supporting the market. These collaborations often aim to advance research, develop new applications, and broaden the reach of flow cytometry technology. Apart from this, the manufacturers are introducing education and training services, such as workshops, webinars, or online tutorials to help users fully utilize the potential of flow cytometry in their work. Therefore, it is significantly supporting the market. Moreover, key players are providing strong customer service and technical support, which is creating a positive market outlook.

The report has provided a comprehensive analysis of the competitive landscape in the global flow cytometry market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Agilent Technologies Inc.
Apogee Flow Systems Ltd.
BD (Becton, Dickinson and Company)
Beckman Coulter Inc. (Danaher Corporation)
Bio-RAD Laboratories Inc.
Enzo Life Sciences Inc.
Luminex Corporation
Merck KGaA
Sony Biotechnology Inc.
Sysmex Partec GmbH
Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1.What was the size of the global flow cytometry market in 2024?
2.What is the expected growth rate of the global flow cytometry market during 2025-2033?
3.What are the key factors driving the global flow cytometry market?
4.What has been the impact of COVID-19 on the global flow cytometry market?
5.What is the breakup of the global flow cytometry market based on the product and service?
6.What is the breakup of the global flow cytometry market based on the technology?
7.What is the breakup of the global flow cytometry market based on the application?
8.What is the breakup of the global flow cytometry market based on the end-user?
9.What are the key regions in the global flow cytometry market?
10.Who are the key players/companies in the global flow cytometry market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Flow Cytometry Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product and Service

6.1 Instruments
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Reagents and Consumables
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Accessories
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Software
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Services
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Technology

7.1 Cell-Based Flow Cytometry
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Bead-Based Flow Cytometry
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Application

8.1 Oncology
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Drug Discovery
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Disease Diagnosis
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Stem Cell Therapy
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Organ Transplantation
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Hematology
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
8.7 Others
- 8.7.1 Market Trends
- 8.7.2 Market Forecast

9 Market Breakup by End-User

9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Academic and Research Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Pharmaceutical and Biotechnology Companies
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Agilent Technologies Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Apogee Flow Systems Ltd.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 BD (Becton, Dickinson and Company)
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Beckman Coulter Inc. (Danaher Corporation)
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 SWOT Analysis
- 14.3.5 Bio-RAD Laboratories Inc.
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Enzo Life Sciences Inc.
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
- 14.3.7 Luminex Corporation
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Merck KGaA
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Sony Biotechnology Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
- 14.3.10 Sysmex Partec GmbH
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
- 14.3.11 Thermo Fisher Scientific Inc.
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
  - 14.3.11.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Flow Cytometry Market: Major Drivers and Challenges
Figure 2: Global: Flow Cytometry Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Flow Cytometry Market: Breakup by Product and Service (in %), 2024
Figure 4: Global: Flow Cytometry Market: Breakup by Technology (in %), 2024
Figure 5: Global: Flow Cytometry Market: Breakup by Application (in %), 2024
Figure 6: Global: Flow Cytometry Market: Breakup by End-User (in %), 2024
Figure 7: Global: Flow Cytometry Market: Breakup by Region (in %), 2024
Figure 8: Global: Flow Cytometry Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 9: Global: Flow Cytometry (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Flow Cytometry (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Flow Cytometry (Reagents and Consumables) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Flow Cytometry (Reagents and Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Flow Cytometry (Accessories) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Flow Cytometry (Accessories) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Flow Cytometry (Software) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Flow Cytometry (Software) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Flow Cytometry (Services) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Flow Cytometry (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Flow Cytometry (Cell-Based) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Flow Cytometry (Cell-Based) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Flow Cytometry (Bead-Based) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Flow Cytometry (Bead-Based) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Flow Cytometry (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Flow Cytometry (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Flow Cytometry (Drug Discovery) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Flow Cytometry (Drug Discovery) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Flow Cytometry (Disease Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Flow Cytometry (Disease Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Flow Cytometry (Stem Cell Therapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Flow Cytometry (Stem Cell Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Flow Cytometry (Organ Transplantation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Flow Cytometry (Organ Transplantation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Flow Cytometry (Hematology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Flow Cytometry (Hematology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Flow Cytometry (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Flow Cytometry (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: Flow Cytometry (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: Flow Cytometry (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Global: Flow Cytometry (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Global: Flow Cytometry (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Global: Flow Cytometry (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Global: Flow Cytometry (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Global: Flow Cytometry (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Global: Flow Cytometry (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: North America: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: North America: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: United States: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: United States: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Canada: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Canada: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Asia Pacific: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Asia Pacific: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: China: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: China: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Japan: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Japan: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: India: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: India: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: South Korea: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: South Korea: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Australia: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Australia: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Indonesia: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Indonesia: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Others: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Others: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Europe: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Europe: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Germany: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Germany: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: France: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: France: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: United Kingdom: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: United Kingdom: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Italy: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Italy: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Spain: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Spain: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Russia: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Russia: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Others: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Others: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Latin America: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Latin America: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Brazil: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Brazil: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Mexico: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 88: Mexico: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 89: Others: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 90: Others: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 91: Middle East and Africa: Flow Cytometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 92: Middle East and Africa: Flow Cytometry Market: Breakup by Country (in %), 2024
Figure 93: Middle East and Africa: Flow Cytometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 94: Global: Flow Cytometry Industry: SWOT Analysis
Figure 95: Global: Flow Cytometry Industry: Value Chain Analysis
Figure 96: Global: Flow Cytometry Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Flow Cytometry Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Flow Cytometry Market Forecast: Breakup by Product and Service (in Million USD), 2025-2033
Table 3: Global: Flow Cytometry Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 4: Global: Flow Cytometry Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Flow Cytometry Market Forecast: Breakup by End-User (in Million USD), 2025-2033
Table 6: Global: Flow Cytometry Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Flow Cytometry Market: Competitive Structure
Table 8: Global: Flow Cytometry Market: Key Players

02-2729-4219

+886-2-2729-4219